Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
- 10 May 2007
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 197 (1), 237-241
- https://doi.org/10.1016/j.atherosclerosis.2007.03.034
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapyActa Endocrinologica, 2007
- ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)Journal of Vascular and Interventional Radiology, 2006
- Should we measure routinely the LDL peak particle size?International Journal of Cardiology, 2006
- Low-density lipoprotein size and cardiovascular risk assessmentQJM: An International Journal of Medicine, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetesMetabolism, 2005
- Lipid Triad or Atherogenic Lipoprotein Phenotype: A Role in Cardiovascular Prevention?Journal of Atherosclerosis and Thrombosis, 2005
- Low-density-lipoprotein peak particle size in a Mediterranean populationEuropean Journal of Clinical Investigation, 2003
- Metabolic origins and clinical significance of LDL heterogeneityJournal of Lipid Research, 2002
- Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiencycclm, 1984